FDA Approves First AI to Quantify Coronary Artery Inflammation
EricTopol · x · 2026-07-30
Renowned cardiologist Eric Topol announced that the FDA has approved the first AI tool capable of quantifying coronary artery inflammation (developed by CaristoHeart).
In a linked deep-dive article, he notes this is a major breakthrough in heart disease prevention. Cardiology has been obsessed with fixing blockages for 40 years, but is now experiencing a massive shift towards non-obstructive disease assessment. By analyzing the fat attenuation index around blood vessels, the newly approved AI imaging tool can identify high-risk, vulnerable plaques, potentially leading to a significant reduction in heart attacks.
Related event: FDA Approves First AI Tool for Quantifying Coronary Artery Inflammation(2 posts)→
More from Apps
- Gamma 5 Recap Slides Quote Verbatim and Cite Sources on Every Bullet — aakashgupta · 2026-10-16
- Hands-on With Gamma 5: Feed It a Keynote, Get a Six-Slide Recap With Zero Questions — aakashgupta · 2026-10-16
- Why All AI-Generated Decks Look Alike: Six-Word Prompts Leave Too Many Blanks — aakashgupta · 2026-10-16
- Duke Study of 4,439 People Finds Coworkers Quietly Rate AI Users as Lazier — aakashgupta · 2026-10-16
- Academic shares workshop slides and code for practical AI workflows in research — JeremyNguyenPhD · 2026-10-16
- Dev Building AI Nutrition Coach for Travelers Open-Sources Mealsight Vision+Voice Workflow — HowDevelop · 2026-10-16